NYU Langone Health
The Director of the Solid Tumor Cell Therapy Program leads the advancement of novel solid tumor immunotherapy approaches and collaborates across disease subtypes and disciplines.
Headquarters
New York, New York, United States
Company Size
10001+ employees
Founded
1841
NYU Langone Health is one of the nation’s top integrated academic health systems, dedicated to patient care, education, and research. It provides comprehensive clinical services through its hospitals and outpatient sites, integrating frontline medicine with medical education and translational science. The system emphasizes innovation and quality, training the next generation of clinicians while advancing medical knowledge. By delivering coordinated care and cutting-edge treatments, NYU Langone Health serves patients and communities with a focus on outcomes and discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NYU Langone Health.
NYU Langone Health didn’t post a salary, so this is our estimate from similar listings.
Post-Doc Research Associate
PeopleAdmin
Global Product Leader- Cell Therapy, Solid Tumor Franchise
AstraZeneca
Cancer Immunotherapy/Tumor Immunology (RISE THRIVE)
University of Wisconsin–Madison
Physician – Internal Medicine, Medical Oncology Physician/faculty (Open Rank/Track Faculty)…ASCO AD
The Ohio State University
Clinical Researcher in Solid Tumor Oncology - GI
Tulane University
Staff Nurse / 36 Hours Rotating/ Oncology/Research 9AB BWH
Mass General Brigham